Delivery of Medicines for the Needs of Mbal Tender - 144437031

Procurement Summary

Country: Bulgaria

Summary: Delivery of Medicines for the Needs of Mbal "Lozenets" Ead under Pls, by Specific Items - Part 3

Deadline: 03 Aug 2026

Posting Date: 02 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 144437031

Document Ref. No.: 455219-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: EUR 590.83

CPV Classification

33600000 - Pharmaceutical products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Alteplase 50 mg Fondaparinux 2, 5 mg/0, 5 ml Fondaparinux 7, 5 mg/0, 6 ml Human fibrinogen 1 g Human Prothrombin Complex 500 IU Coagulation factor IX, II, VII and X (комбинация) 600 IU Eptacog alfa (activated) 2 mg (100 KIU) Iron (III)-hydroxide sucrose complex 20 mg/ml - 5 ml Ferric derisomaltose 100 mg/ml - 5 ml Iron(III)-hydroxide dextran complex 50 mg/ml - 2 ml Cyanocobalamin 1000 mcg/ml - 1 ml Erythropoietin (Epoetin alfa) 2000 IU/1, 0 ml Erythropoietin (Epoetin alfa) 3000 IU/0, 3 ml Erythropoietin (Epoetin alfa) 4000 IU/0.4 ml Darbepoetin alfa 40 µg (100 µg/ml) - 0.4 ml Albumin 200 g/l - 100 ml Albumin 50 g/l - 250 ml Amino acids 500 ml / 8% Amino acids 100.0 g/l - 500 ml Purified soybean oil 200 g/1000 ml - 500 ml Delivery of medicines for the needs of Lozenets Hospital EAD under PLC, by specific positions - part 3 ​​​​​​​​​​​The subject of the public procurement is the periodic supply on request of medicines for the needs of "Lozenets Hospital" EAD. The subject of the procurement includes periodically recurring supplies of medicines in 20 separate items by types and quantities, detailed in the Technical Specification - Appendix No. 1. 1. Alteplase 50 mg 2. Fondaparinux 2.5 mg/0.5 ml 3. Fondaparinux 7.5 mg/0.6 ml 4. Human fibrinogen 1 g 5. Human Prothrombin Complex 500 IU 6. Coagulation factor IX, II, VII and X (комбинация) 600 IU 7.Eptacog alfa (activated) 2 mg (100 KIU) 8.Iron (III)-hydroxide sucrose complex 20 mg/ml - 5 ml 9.Ferric derisomaltose 100 mg/ml - 5 ml 10.Iron(III)-hydroxide dextran compl...
Document Type: Contract Notice Reference Number: 590077 Contract Type: supplies Estimated Value: 590.83 - EUR Authority Type: body-pl Doc Title: Delivery of medicines for the needs of MBAL "Lozenets" EAD under PLS, by specific items - part 3 Dispatch Date: 2026-07-01 Publish Date: 2026-07-02 Submission Date: 2026-08-03

Documents

 Tender Notice